Woozfree Tablet MD contains a combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg, formulated to prevent and treat motion sickness and vertigo. Cinnarizine, a selective calcium channel blocker with antihistaminic properties, acts by inhibiting vestibular stimulation in the inner ear, thereby reducing nausea and dizziness associated with motion-induced disturbances. Dimenhydrinate, an antihistamine with antiemetic properties, complements this effect by blocking H1 histamine receptors and exerting anticholinergic activity, which helps alleviate nausea, vomiting, and balance disorders. This synergistic combination provides effective relief from symptoms such as nausea, vomiting, dizziness, and imbalance commonly encountered in conditions like motion sickness, labyrinthitis, and Meniere’s disease. Woozfree Tablet MD is indicated for adults and children above 12 years of age. It should be administered as directed by a healthcare professional, typically 30 minutes prior to travel or onset of symptoms, with dosage adjustments based on clinical response. Caution is advised in patients with a history of hypersensitivity to antihistamines, glaucoma, asthma, or prostatic hypertrophy. Common side effects may include drowsiness, dry mouth, and gastrointestinal discomfort. Patients are advised to avoid alcohol and activities requiring mental alertness while using this medication.